Diagnosis and management of multiple sclerosis: MRI in clinical practice.
Clinical practice
Diagnosis
Disease-modifying treatments
MRI
Monitoring
Multiple sclerosis
Journal
Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
17
01
2020
accepted:
18
05
2020
revised:
12
05
2020
pubmed:
31
5
2020
medline:
21
5
2021
entrez:
31
5
2020
Statut:
ppublish
Résumé
Recent changes in the understanding and management of multiple sclerosis (MS) have increased the role of MRI in supporting diagnosis and disease monitoring. However, published guidelines on the use of MRI in MS do not translate easily into different clinical settings and considerable variation in practice remains. Here, informed by published guidelines for the use of MRI in MS, we identified a clinically informative MRI protocol applicable in a variety of clinical settings, from district general hospitals to tertiary centres. MS specialists geographically representing the UK National Health Service and with expertise in MRI examined existing guidelines on the use of MRI in MS and identification of challenges in their applications in various clinical settings informed the formulation of a feasible MRI protocol. We identified a minimum set of MRI information, based on clinical relevance, as well as on applicability to various clinical settings. This informed the selection of MRI acquisitions for scanning protocols, differentiated on the basis of their purpose and stage of the disease, and indication of timing for scans. Advice on standardisation of MRI requests and reporting, and proposed timing and frequency of MRI scans were generated. The proposed MRI protocol can adapt to a range of clinical settings, aiding the impetus towards standardisation of practice and offering an example of research-informed service improvement to support optimisation of resources. Other neurological conditions, where a gap still exists between published guidelines and their clinical implementation, may benefit from this same approach.
Sections du résumé
BACKGROUND
BACKGROUND
Recent changes in the understanding and management of multiple sclerosis (MS) have increased the role of MRI in supporting diagnosis and disease monitoring. However, published guidelines on the use of MRI in MS do not translate easily into different clinical settings and considerable variation in practice remains. Here, informed by published guidelines for the use of MRI in MS, we identified a clinically informative MRI protocol applicable in a variety of clinical settings, from district general hospitals to tertiary centres.
METHODS
METHODS
MS specialists geographically representing the UK National Health Service and with expertise in MRI examined existing guidelines on the use of MRI in MS and identification of challenges in their applications in various clinical settings informed the formulation of a feasible MRI protocol.
RESULTS
RESULTS
We identified a minimum set of MRI information, based on clinical relevance, as well as on applicability to various clinical settings. This informed the selection of MRI acquisitions for scanning protocols, differentiated on the basis of their purpose and stage of the disease, and indication of timing for scans. Advice on standardisation of MRI requests and reporting, and proposed timing and frequency of MRI scans were generated.
CONCLUSIONS
CONCLUSIONS
The proposed MRI protocol can adapt to a range of clinical settings, aiding the impetus towards standardisation of practice and offering an example of research-informed service improvement to support optimisation of resources. Other neurological conditions, where a gap still exists between published guidelines and their clinical implementation, may benefit from this same approach.
Identifiants
pubmed: 32472179
doi: 10.1007/s00415-020-09930-0
pii: 10.1007/s00415-020-09930-0
pmc: PMC7501096
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2917-2925Subventions
Organisme : Novartis Pharmaceuticals UK Limited
ID : Support for meeting
Références
JAMA Neurol. 2015 Feb;72(2):152-8
pubmed: 25531931
Ther Adv Neurol Disord. 2019 Apr 22;12:1756286419840593
pubmed: 31040881
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Radiology. 2017 Nov;285(2):546-554
pubmed: 28653860
Can J Neurol Sci. 2015 May;42(3):159-67
pubmed: 25896163
Neurol Sci. 2013 Dec;34(12):2085-93
pubmed: 23828372
J Neurol. 2006 Mar;253(3):287-93
pubmed: 16151600
Neurology. 2017 Apr 11;88(15):1439-1444
pubmed: 28283598
Br J Radiol. 2019 Sep;92(1101):20180926
pubmed: 30994035
Rofo. 2014 May;186(5):484-8
pubmed: 24347360
Brain Behav. 2016 Jan 12;6(2):e00422
pubmed: 27110445
Lancet Neurol. 2011 Aug;10(8):745-58
pubmed: 21777829
Nat Rev Neurol. 2015 Oct;11(10):597-606
pubmed: 26369511
J Neurol Sci. 2012 Dec 15;323(1-2):104-12
pubmed: 23006974
J Neurol Neurosurg Psychiatry. 2016 Feb;87(2):117-25
pubmed: 26492930
Neurology. 2013 Jan 1;80(1):69-75
pubmed: 23243070
J Neurol Sci. 2011 May 15;304(1-2):55-60
pubmed: 21402386
Acta Neurol Scand. 2017 Jan;135(1):17-24
pubmed: 27558404
Mult Scler. 2011 Dec;17(12):1432-40
pubmed: 21729978
Nat Rev Neurol. 2016 Dec;12(12):714-722
pubmed: 27834394
J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1138-45
pubmed: 27530808
Expert Rev Neurother. 2009 Sep;9(9):1341-59
pubmed: 19769449
Neurology. 2014 Jul 15;83(3):278-86
pubmed: 24871874
Lancet Neurol. 2016 Mar;15(3):292-303
pubmed: 26822746
AJNR Am J Neuroradiol. 2016 Mar;37(3):394-401
pubmed: 26564433
Mult Scler. 2019 Jul;25(8):1141-1149
pubmed: 29985084
Curr Opin Neurol. 2014 Jun;27(3):260-70
pubmed: 24739400
Ann Neurol. 2001 Mar;49(3):290-7
pubmed: 11261502
Neurology. 2004 Jan 27;62(2):226-33
pubmed: 14745058
AJNR Am J Neuroradiol. 2003 May;24(5):922-9
pubmed: 12748095
Ann Neurol. 2014 Dec;76(6):802-12
pubmed: 25273271
Brain. 2008 Mar;131(Pt 3):808-17
pubmed: 18234696
N Engl J Med. 1998 Jul 30;339(5):285-91
pubmed: 9682040
Brain. 1996 Jun;119 ( Pt 3):701-8
pubmed: 8673483
J Neurol Sci. 2000 Mar 15;174(2):85-91
pubmed: 10727693
J Neurol Sci. 2005 Dec 15;239(1):95-9
pubmed: 16209877
Radiology. 2002 Apr;223(1):46-56
pubmed: 11930047